Open-Label, Phase 2 Study of Blinatumomab As Second Salvage Therapy in Adults with Relapsed/Refractory Aggressive B-Cell Non-Hodgkin Lymphoma

著录项

• 来源
  《Blood: The Journal of the American Society of Hematology》 |2018年第novaelatreatmentappr期|共3页
• 作者

  Coyle Luke; Morley Nicholas J.; Rambaldi Alessandro; Mason Kylie D.; Verhoef Gregor; Furness Caroline; Zhang Alicia; Jung A. Scott; Franklin Janet L.;

  展开▼
• 作者单位

  Royal North Shore Hosp Dept Haematol Sydney NSW Australia;

  Sheffield Teaching Hosp NHS Fdn Trust Dept Haematol Sheffield S Yorkshire England;

  Univ Milan Dept Hematol Oncol Bergamo Italy;

  Peter MacCallum Canc Ctr Dept Clin Haematol Melbourne Vic Australia;

  Univ Hosp Leuven Dept Hematol Leuven Belgium;

  Royal Marsden NHS Fdn Trust Haematooncol London England;

  Amgen Inc Global Biostat Sci Thousand Oaks CA 91320 USA;

  Amgen Inc Global Dev Thousand Oaks CA 91320 USA;

  Amgen Inc Global Dev Thousand Oaks CA 91320 USA;

  展开▼
• 收录信息
• 原文格式 PDF
• 正文语种 eng
• 中图分类 血液及淋巴系疾病;
• 关键词